Health Care & Life Sciences » Medical Equipment & Supplies | Tandem Diabetes Care Inc.

Tandem Diabetes Care Inc. | Income Statement

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
29,006.60
49,722.00
72,850.00
84,248.00
107,601.00
183,866
Cost of Goods Sold (COGS) incl. D&A
22,840.20
34,474.00
44,322.00
51,826.00
57,894.00
94,044
Gross Income
6,166.40
15,248.00
28,528.00
32,422.00
49,707.00
89,822
SG&A Expense
55,600.40
90,912.00
95,584.00
101,643.00
107,038.00
134,453
EBIT
49,434.00
75,664.00
-
78,051.00
62,944.00
44,631
Unusual Expense
9,001.70
-
-
-
1,021.00
71,807
Interest Expense
4,709.80
3,901.00
3,741.00
5,707.00
11,341.00
7,584
Pretax Income
63,138.80
79,453.00
72,408.00
83,462.00
73,025.00
122,560
Income Tax
-
71.00
10.00
15.00
8.00
51
Consolidated Net Income
63,138.80
79,524.00
72,418.00
83,447.00
73,033.00
122,611
Net Income
63,138.80
79,524.00
72,418.00
83,447.00
73,033.00
122,611
Net Income After Extraordinaries
63,138.80
79,524.00
72,418.00
83,447.00
73,033.00
122,611
Net Income Available to Common
63,138.80
79,524.00
72,418.00
83,447.00
73,033.00
122,611
EPS (Basic)
214.60
34.20
25.00
27.30
12.86
2.55
Basic Shares Outstanding
294.20
2,327.20
2,892.30
3,057.00
5,677.00
48,129
EPS (Diluted)
214.61
34.17
25.04
27.30
12.86
2.55
Diluted Shares Outstanding
294.20
2,327.20
2,892.30
3,057.00
5,677.00
48,129
EBITDA
46,267.20
71,275.00
64,175.00
72,562.00
56,078.00
38,810
Other Operating Expense
-
-
1,948.00
8,830.00
5,613.00
-
Non-Operating Interest Income
6.60
112.00
337.00
296.00
239.00
1,462

About Tandem Diabetes Care

View Profile
Address
11075 Roselle Street
San Diego California 92121
United States
Employees -
Website http://www.tandemdiabetes.com
Updated 07/08/2019
Tandem Diabetes Care, Inc. engages in the design, development, and commercialization of products for people with insulin-dependent diabetes. Its flagship product, t:slim X2 Insulin Delivery System, operates as a small insulin pump. The company was founded by Paul M.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.